Panel Discussion

Sunday, March 9, 2025

4:47 PM - 5:10 PM ET

Panel Moderator(s)

Sam Chitsaz, MD FACC FSCAI

Interventional Cardiologist
Sutter Health

No relationships to disclose
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

No relationships to disclose

Panel Discussant(s)

Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure information not submitted.
Emmanouil S. Brilakis, MD, PhD

Director, Center for Advanced Coronary Interventions
Minneapolis Heart Institute
Minneapolis, Minnesota, United States

No relationships to disclose
Fabio S. Brito, Jr., MD

Director, Structural Heart Interventions
Instituto do Coracao (InCor)

Disclosure information not submitted.
Tim A. Fischell, MD, FACC

Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States

Disclosure information not submitted.
Dipti Itchhaporia, MD

Clinical Professor
University of California, Irvine

Disclosure(s): No financial relationships to disclose
Ryan D. Madder, MD

Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States

No relationships to disclose
Bradley H. Strauss, MD, PhD

Staff Cardiologist
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

No relationships to disclose

Disclosure(s):

Israel Barbash, MD: No financial relationships to disclose

Sam Chitsaz, MD FACC FSCAI: No financial relationships to disclose

Chaim Shaul Lotan, MD: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Emmanouil S. Brilakis, MD, PhD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Tim A. Fischell, MD, FACC: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Dipti Itchhaporia, MD: No financial relationships to disclose

Ryan D. Madder, MD: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiowave Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Corindus: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gentuity: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Microbot Medical: Grant/Research Support (Ongoing); Nanoflex Robotics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); RapidAI: Consulting Fees (e.g., advisory boards) (Ongoing); Spectrawave: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Bradley H. Strauss, MD, PhD: RBY Medical: company founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)